Q32 Bio

1 follower


Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.

Industries

Employees

11-50

Links

Org chart

Jodie Morrison
Acting CEO

Jodie Morrison

Collapse
Shelia Violette
Co-Founder & Chief Scientific Officer
Jason Campagna
Chief Medical Officer
David Appugliese
SVP & Head of People
Maria Marzilli
EVP, Corporate Strategy & Program Operations
Bill Lundberg
Independent Director
Dessi McEntee, MS, DABT
Associate Director, Toxicology
Fei Liu
Director, Pharmacology
Hong Wu, MD, PhD, DABT
Vp, Head Of Translational, Clinical Pharm, & Nonclinical Dev
Isidora Tošić
New Product Planning Manager
Joel Scherer
Vice President, Clinical Development, Immunotherapeutics
Justin Rogers
Director, Quality Assurance
Reena Malik
Associate Director - Regulatory Affairs
Theresa Carbeau
Director, CMC
Eric Bell
Senior Vice President Finance And Controller